Filing Details
- Accession Number:
- 0001179110-18-008050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-05 16:06:36
- Reporting Period:
- 2018-06-01
- Accepted Time:
- 2018-06-05 16:06:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1650664 | Editas Medicine Inc. | EDIT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1592469 | Katrine Bosley | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-06-01 | 6,214 | $37.18 | 1,295,751 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-06-01 | 1,019 | $37.81 | 1,294,732 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-06-01 | 800 | $39.15 | 1,293,932 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-06-01 | 300 | $39.96 | 1,293,632 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
- This transaction was executed in multiple trades at prices ranging from $36.67 to $37.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $37.67 to $38.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $38.76 to $39.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $39.785 to $40.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.